Clinical Trial Update: VITAL - the Heart Failure With Reduced Ejection Fraction Sub-study

View source ↗

Summary

This document provides an update on the VITAL study’s sub-study focusing on heart failure with reduced ejection fraction, indicating it is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Snippet

Sponsor: University College, London | Conditions: Heart Failure With Reduced Ejection Fraction | Status: NOT_YET_RECRUITING